Author + information
- Received July 30, 2014
- Revision received September 27, 2014
- Accepted October 28, 2014
- Published online February 3, 2015.
- Pratik B. Sandesara, MD∗,
- Cameron T. Lambert, MD∗,
- Neil F. Gordon, MD, PhD, MPH†,
- Gerald F. Fletcher, MD‡,
- Barry A. Franklin, PhD§,
- Nanette K. Wenger, MD∗ and
- Laurence Sperling, MD∗∗ ()
- ∗Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia
- †Intervent International, Savannah, Georgia
- ‡Mayo Clinic, Rochester, Minnesota
- §Department of Cardiovascular Medicine, William Beaumont Hospital, Royal Oak, Michigan
- ↵∗Reprint requests and correspondence:
Dr. Laurence Sperling, Emory University, 1365 Clifton Road, NE, Building A, Suite 2200, Atlanta, Georgia 30322.
Atherosclerotic cardiovascular disease (ASCVD) continues to increase annually in the United States along with its associated enormous costs. A multidisciplinary cardiac rehabilitation (CR) and risk reduction program is an essential component of ASCVD prevention and management. Despite the strong evidence for CR in the secondary prevention of ASCVD, it remains vastly underutilized due to significant barriers. The current model of CR delivery is unsustainable and needs significant improvement to provide cost-effective, patient-centered, comprehensive secondary ASCVD prevention.
Dr. Gordon is the CEO of Intervent International, LLC. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Received July 30, 2014.
- Revision received September 27, 2014.
- Accepted October 28, 2014.
- 2015 American College of Cardiology Foundation